{"id":21004,"date":"2016-09-07T14:26:00","date_gmt":"2010-09-07T14:26:00","guid":{"rendered":"http:\/\/www.accessrx.com\/blog\/?p=212"},"modified":"2010-09-07T14:26:00","modified_gmt":"2010-09-07T14:26:00","slug":"fda-fails-to-police-drug-medication-ads-effectively-a907","status":"publish","type":"post","link":"https:\/\/www.edrugstore.com\/blog\/current-health-news\/fda-fails-to-police-drug-medication-ads-effectively-a907\/","title":{"rendered":"FDA Marketing Police Cannot Keep Up With $4.8 Billion Pharma Drug Advertising Budget"},"content":{"rendered":"

\"TheYou can buy a lot of ads for $4.8 billion. That\u2019s how much money the pharmaceutical industry spends each year marketing its products directly to consumers (DTCA).<\/p>\n

The problem is, the U.S. Food and Drug Administration (FDA) can\u2019t keep up with their job of policing the ads. Not even close. It’s the FDA\u2019s job to ensure ads are fair, do not mislead, and warn about side effects.<\/p>\n

The U.S. is the only developed country other than New Zealand that allows direct-to-consumer advertising for drugs and other medical products \u2013 a huge point of contention among consumer groups.<\/p>\n

The special report by Reuters that outlines the inability of the FDA\u2019s oversight is about 4,000 words long, so let\u2019s stick to the highlights. It won\u2019t take long for you to be unimpressed\u2026<\/p>\n